아시아태평양의 항균 외과수술용 봉합사 시장 : 예측 - 시장 범위, 부문, 동향, 경쟁 분석(2021-2031년)

The Asia Pacific antimicrobial surgical suture market size is expected to reach US$ 124.73 million by 2031 from US$ 51.68 million in 2023. The market is estimated to record a CAGR of 11.7% from 2024-2031.

Executive Summary and Asia Pacific Antimicrobial Surgical Suture Market Analysis:

The Asia Pacific antimicrobial surgical suture market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region is the fastest-growing market for antimicrobial surgical sutures in global scenarios. Asia Pacific is expected to witness the highest growth over the forecast period.

The antimicrobial surgical suture market in this region is expected to grow owing to factors such as rising plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, the increase in the number of research studies and the surge in healthcare expenditure are anticipated to fuel the market growth during the forecast period.

Asia Pacific Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Asia Pacific antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Asia Pacific antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Asia Pacific antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Asia Pacific antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Asia Pacific Antimicrobial Surgical Suture Market Outlook

The RMIT Centre for Materials Innovation and Future Fashion is one of the organizations focusing on developing new, smart antimicrobial sutures to reduce the prevalence of surgical site infections. The center's suture products are made from materials that glow during medical imaging procedures; these stitches have the potential to replace mesh implants as promising alternatives. They can be beneficial in monitoring patient recovery progress, in addition to their impressive antimicrobial properties, preventing infections and killing 99% of highly drug-resistant bacteria after 6 hours of contact at body temperature. It may also significantly reduce surgery duration and increase surgical accuracy in general through the ability to visualize mesh location accurately on preoperative imaging.

MIT engineers have created "smart" sutures that can not only hold tissues in place but also sense inflammation and deliver drugs. The new sutures are made from animal tissue, similar to the "catgut" sutures created by the ancient Romans. These sutures are coated with hydrogels that can be integrated with sensors, drugs, or even cells that release therapeutic substances. These sutures could be particularly beneficial for the treatment of Crohn's disease patients who need to undergo colectomy due to excessive scarring or inflammation. MIT's smart sutures hold the tissue in place and identify inflammation as an early warning sign indicating the improper functioning of the resealed intestines. The hydrogel coating of these sutures carries drugs through microparticles composed of FDA-approved polymers such as PLA and PLGA, which also aid in a controlled drug release rate. This approach could also be used to deliver other drugs, such as chemotherapy drugs or antibiotics. Therefore, developments in smart antimicrobial surgical sutures are expected to bring new growth trends in the antimicrobial surgical sutures market growth in the coming years.

Asia Pacific Antimicrobial Surgical Suture Market Country Insights

Based on country, the Asia Pacific antimicrobial surgical suture market comprises Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share in 2023.

China performs more plastic surgery operations than any country except America. According to a report, over 22 million plastic surgeries were performed in China in 2020. This includes only the procedures performed by licensed plastic surgeons, which is likely higher due to the presence of unlicensed plastic surgeons in China. China's changing attitudes toward self-image, growing wealth, technological advancements, and obsession with celebrity culture fuel this growth. In China, beauty is deemed an advantage in the competitive mid-level workplace because job applicants are often required to submit a photograph with their application.

Apart from Plastic surgeries, orthopedic and general surgeries are also propelling the market for hospital sutures in China. In August 2020, Beijing Haidian Hospital officially introduced orthopedic surgery robots in May 2020 and completed more than 400 robotic surgeries by the end of August 2021. The orthopedic surgical robot could dynamically analyze the patient's anatomy and the spine-hip relation and carry out individualized surgery planning precisely as planned.

Asia Pacific Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Antimicrobial Surgical Suture Market - Key Market Dynamics

• 4.1 Market Drivers:
  • 4.1.1 Surging Prevalence of Surgical Site Infections
  • 4.1.2 Increasing Cases of Chronic Wounds and Surgeries
• 4.2 Market Restraints
  • 4.2.1 Non-invasive Alternatives to Stitches
• 4.3 Market Opportunities
  • 4.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
• 4.4 Future Trends
  • 4.4.1 Smart Antimicrobial Sutures
• 4.5 Impact of Drivers and Restraints:

5. Antimicrobial Surgical Suture Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
• 5.2 Asia Pacific Antimicrobial Surgical Suture Market Forecast Analysis

6. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Type

• 6.1 Triclosan Antimicrobial Suture
  • 6.1.1 Overview
  • 6.1.2 Triclosan Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 6.2 Chlorhexidine Antimicrobial Suture
  • 6.2.1 Overview
  • 6.2.2 Chlorhexidine Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Raw Materials

• 7.1 Polyglactin 910 Antimicrobial Suture
  • 7.1.1 Overview
  • 7.1.2 Polyglactin 910 Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 7.2 Poliglecaprone 25
  • 7.2.1 Overview
  • 7.2.2 Poliglecaprone 25: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Polyglycolic Acid
  • 7.3.1 Overview
  • 7.3.2 Polyglycolic Acid: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Application

• 8.1 Cardiovascular Surgery
  • 8.1.1 Overview
  • 8.1.2 Cardiovascular Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.2 General Surgery
  • 8.2.1 Overview
  • 8.2.2 General Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Ophthalmic Surgery
  • 8.3.1 Overview
  • 8.3.2 Ophthalmic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.4 Gynaecological Surgery
  • 8.4.1 Overview
  • 8.4.2 Gynaecological Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.5 Orthopedic Surgery
  • 8.5.1 Overview
  • 8.5.2 Orthopedic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.6 Plastic Surgery
  • 8.6.1 Overview
  • 8.6.2 Plastic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.7 Veterinary Surgery
  • 8.7.1 Overview
  • 8.7.2 Veterinary Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.8 Dental Surgery
  • 8.8.1 Overview
  • 8.8.2 Dental Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 8.9 Others
  • 8.9.1 Overview
  • 8.9.2 Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by End User

• 9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Overview
  • 9.2.2 Ambulatory Surgical Centers: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Antimicrobial Surgical Suture Market - Country Analysis

• 10.1 Asia Pacific
  • 10.1.1 Asia Pacific Antimicrobial Surgical Suture Market Overview
  • 10.1.2 Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast Analysis - by Country
    • 10.1.2.1 Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.1.1 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.1.2 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.1.3 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.1.4 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
    • 10.1.2.2 China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.2.1 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.2.2 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.2.3 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.2.4 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
    • 10.1.2.3 India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.3.1 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.3.2 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.3.3 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.3.4 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
    • 10.1.2.4 South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.4.1 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.4.2 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.4.3 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.4.4 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
    • 10.1.2.5 Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.5.1 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.5.2 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.5.3 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.5.4 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
    • 10.1.2.6 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.6.1 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
      • 10.1.2.6.2 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
      • 10.1.2.6.3 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
      • 10.1.2.6.4 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies
  • 11.2.1 Overview
• 11.3 Company Market Share Analysis (%), 2023

12. Company Profiles

• 12.1 TI Medical
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Healthium Medtech Limited
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Meril Life Sciences Pvt Ltd
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Johnson & Johnson
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Futura Surgicare Pvt Ltd (Dolphin Sutures)
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Advanced MedTech Solutions Pvt. Ltd.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Internacional Farmaceutica SA
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Glossary of Terms